Pharma On The Hunt For Oncology Partners Across Modalities

For Novel Targets, New Approaches To Known Targets

The Inaugural AACR Oncology Industry Partnering Event gave pharma firms an opportunity to tell potential cancer drug collaborators what they need from external sources.

Tumor microenvironment concept with cancer cells, T-Cells, nanoparticles, cancer associated fibroblast layer of tumor microenvironment
Pharma firms expressed interest in new drug candidates, platforms and other technologies • Source: Shutterstock

More from Deals

More from Business